Enact (ACT) Proxy Filing summary

Executive summary

• Achieved record net income of $688 million in 2024, with insurance in-force reaching $269 billion and operating expenses reduced by 2% despite inflationary pressures.

• Returned over $1 billion to shareholders since IPO through share repurchases and dividends, with $354 million returned in 2024 alone.

• Maintained strong capital and liquidity, with PMIERS sufficiency at $2.1 billion (167% above requirements) at year-end.

• Helped nearly 140,000 households achieve homeownership in 2024, with a market share of approximately 17%.

• Advanced into reinsurance with Enact Re, participating in all GSE Credit Risk Transfer transactions in 2024.

Voting matters and shareholder proposals

• Stockholders will vote on: (1) election of eleven director nominees, (2) advisory approval of executive compensation, and (3) ratification of KPMG as independent auditor for 2025.

• Board recommends voting FOR all proposals.

• Each share of common stock is entitled to one vote per proposal.

Board of directors and corporate governance

• Eleven director nominees, eight of whom are independent; board skills include insurance, finance, risk management, and technology.

• Board committees (Audit, Compensation, Nominating & Corporate Governance, Independent Capital, Risk) are majority or fully independent.

• Annual board and committee self-evaluations completed; all directors attended at least 75% of meetings.

• Stockholder rights include annual director elections, special meeting rights, and no poison pill.

• Genworth retains significant board nomination and approval rights under the Master Agreement.